<DOC>
	<DOCNO>NCT00457236</DOCNO>
	<brief_summary>This study prospective , single-center evaluation impact variability platelet response load clopidogrel peri-interventional risk patient undergo PCI .</brief_summary>
	<brief_title>Effect Clopidogrel Loading Risk PCI</brief_title>
	<detailed_description>Background : Platelet response load clopidogrel highly variable . The impact variability peri-interventional risk patient undergo PCI investigate prospectively . Objectives : Our prospective study test hypothesis 30-day clinical outcome elective percutaneous catheter intervention ( PCI ) differs strata define quartile platelet aggregation load 600mg clopidogrel . Further investigate impact variability platelet response long-term outcome PCI . Methods : Our study include consecutive patient undergo elective coronary stent placement . Before PCI , patient receive load dose 600mg clopidogrel follow 75mg daily . Primary end point 30-day composite death , myocardial infarction target lesion revascularization ( MACE ) . Platelet aggregation assess immediately PCI optical aggregometry ( 5µmol/L ADP ) . Sample size calculation base ISAR-REACT comprise cohort similar selection criterion treatment strategy . Thus , assume incidence primary end point 4.2 % . We design study test hypothesis incidence primary end point differ quartile ADP-induced platelet aggregation . We intend power 0.80 detect effect size 0.015 ( example 3-fold risk 4th quartile ) 2-sided P-value le 0.05 . With assumption obtain sample size least 748 aime cohort 800 .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patients undergo elective coronary stenting Pretreatment bolus dose 600mg clopidogrel prior coronary stent implantation Pretreatment aspirin ≥ 100 mg per day least 7 day Age &gt; 18 year Written consent Troponin T admission &gt; 0.03 ng/mL Myocardial infarction fibrinolytic therapy within previous 14 day Cardiogenic shock Contraindication aspirin clopidogrel Oral anticoagulation Pretreatment heparin thienopyridine within previous 14 day Use GP IIb/IIIareceptor antagonist PCI Platelet count &lt; 100.000/µl Severe disorder coagulation system Severe impairment liver kidney function Cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Drug Resistance</keyword>
	<keyword>PCI</keyword>
</DOC>